These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3673113)

  • 1. Studies on the metabolism of aristolochic acids I and II.
    Krumbiegel G; Hallensleben J; Mennicke WH; Rittmann N; Roth HJ
    Xenobiotica; 1987 Aug; 17(8):981-91. PubMed ID: 3673113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Dedı Ková A; Bárta F; Martínek V; Kotalík K; Dušková Š; Mráz J; Arlt VM; Stiborová M; Hodek P
    Chem Res Toxicol; 2020 Nov; 33(11):2804-2818. PubMed ID: 32894017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver.
    Schmeiser HH; Pool BL; Wiessler M
    Carcinogenesis; 1986 Jan; 7(1):59-63. PubMed ID: 3510750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolochic acid I metabolism in the isolated perfused rat kidney.
    Priestap HA; Torres MC; Rieger RA; Dickman KG; Freshwater T; Taft DR; Barbieri MA; Iden CR
    Chem Res Toxicol; 2012 Jan; 25(1):130-9. PubMed ID: 22118289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
    Broschard TH; Wiessler M; Schmeiser HH
    Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.
    Pfau W; Schmeiser HH; Wiessler M
    Carcinogenesis; 1990 Sep; 11(9):1627-33. PubMed ID: 2401053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
    Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
    Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
    Schmeiser HH; Frei E; Wiessler M; Stiborova M
    Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats.
    Chan W; Luo HB; Zheng Y; Cheng YK; Cai Z
    Drug Metab Dispos; 2007 Jun; 35(6):866-74. PubMed ID: 17344338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.
    Arlt VM; Wiessler M; Schmeiser HH
    Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium.
    Schmeiser HH; Pool BL; Wiessler M
    Cancer Lett; 1984 May; 23(1):97-101. PubMed ID: 6378360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the nitric oxide generating effects from aristolochic acid in vitro.
    Xu Q; Ma C; Wang W; Fu X; Tang C; Hattori M
    Eur J Mass Spectrom (Chichester); 2008; 14(4):231-7. PubMed ID: 18756021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.
    Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.